The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Research Article

Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia

Nadine Norton

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Valentina Moskvina

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Derek W Morris

Neuropsychiatric Genetics Group, Department of Psychiatry, Trinity College Dublin, Ireland

Search for more papers by this author
Nicholas J Bray

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Stanley Zammit

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Nigel M Williams

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Hywel J Williams

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Anna C Preece

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Sarah Dwyer

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Jennifer C Wilkinson

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Gillian Spurlock

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
George Kirov

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Paul Buckland

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
John L Waddington

Stanley Research Unit, St. Davnet's Hospital, Monaghan, Ireland

Department of Clinical Pharmacology, Royal College of Surgeons, Dublin, Ireland

Search for more papers by this author
Michael Gill

Neuropsychiatric Genetics Group, Department of Psychiatry, Trinity College Dublin, Ireland

Search for more papers by this author
Aiden P Corvin

Neuropsychiatric Genetics Group, Department of Psychiatry, Trinity College Dublin, Ireland

Search for more papers by this author
Michael J Owen

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Search for more papers by this author
Michael C O'Donovan

Corresponding Author

E-mail address:odonovanmc@cf.ac.uk

Department of Psychological Medicine, Wales School of Medicine, Cardiff, United Kingdom

Department of Psychological Medicine, Wales School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.
Search for more papers by this author
First published: 25 October 2005
Cited by: 104

Abstract

There is now strong evidence that Neuregulin 1 (NRG1) is a susceptibility gene for schizophrenia. NRG1 mediates some of its effects through the tyrosine kinase receptor erbB4, and analysis of gene knock‐out animals suggests that the functional interaction of NRG1 and erbB4 mediates behaviors that may model some aspects of the schizophrenia phenotype in mice. Given these findings, we have sought evidence for association between schizophrenia and erbB4. Mutation screening of erbB4 in 14 DSMIV schizophrenics revealed 15 SNPs, none of which were nonsynonymous. Analysis of the allele frequencies of each SNP in pools of 368 DSMIV schizophrenics and 368 controls provided modest evidence for association with two of the SNPs, although individual genotyping in an extended sample of 680 cases did not confirm this. However, we did find evidence for a significant interaction between the NRG1 “Icelandic” schizophrenia risk haplotype and erbB4 (P = 0.019). The NRG1 and erbB4 interacting marker was further genotyped in an independent sample of 290 cases and 634 controls from Dublin. Interaction between NRG1 and erbB4 remained significant in the combined sample of 970 cases and 1,341 controls, OR = 2.98 (CI: 1.16–7.64), P = 0.01, although it only showed a trend in the Dublin sample alone (P = 0.11, two tailed). Our data require independent replication, but tentatively suggest that NRG1 may mediate its effects on schizophrenia susceptibility through functional interaction with erbB4, and that genetic interaction between variants at the two loci increases susceptibility to schizophrenia. © 2005 Wiley‐Liss, Inc.

Number of times cited: 104

  • , Neuregulin 3 and its roles in schizophrenia risk and presentation, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177, 2, (257-266), (2017).
  • , Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders, F1000Research, 10.12688/f1000research.12155.1, 7, (23), (2018).
  • , Excitotoxicity ☆, Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.65836-1, (2017).
  • , Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia, Medicine, 10.1097/MD.0000000000005920, 96, 8, (e5920), (2017).
  • , Are There Schizophrenia Genetic Markers and Mutations? A Systematic Review and Meta-Analyses, Health, 10.4236/health.2017.95058, 09, 05, (811-838), (2017).
  • , A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution, Molecular Neurobiology, (2017).
  • , Neurological dysfunctions associated with altered BACE1‐dependent Neuregulin‐1 signaling, Journal of Neurochemistry, 136, 2, (234-249), (2015).
  • , Modeling Gene–Gene Interactions in Schizophrenia, Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior, 10.1016/B978-0-12-800981-9.00019-5, (327-343), (2016).
  • , Neuregulin-1 Regulates Cortical Inhibitory Neuron Dendrite and Synapse Growth through DISC1, Neural Plasticity, 10.1155/2016/7694385, 2016, (1-15), (2016).
  • , Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study, Schizophrenia Bulletin, 10.1093/schbul/sbv147, 42, 3, (851-862), (2015).
  • , Neuregulin-1 and schizophrenia in the genome-wide association study era, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2016.06.001, 68, (387-409), (2016).
  • , Glia‐related genes and their contribution to schizophrenia, Psychiatry and Clinical Neurosciences, 69, 8, (448-461), (2015).
  • , Myelin, myelin-related disorders, and psychosis, Schizophrenia Research, 10.1016/j.schres.2014.09.040, 161, 1, (85-93), (2015).
  • , ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children, Brain Imaging and Behavior, 10.1007/s11682-015-9363-y, 9, 1, (128-140), (2015).
  • , Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation, Schizophrenia Research, 10.1016/j.schres.2015.07.006, 168, 1-2, (411-420), (2015).
  • , Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells, Translational Stroke Research, 10.1007/s12975-014-0347-9, 6, 2, (116-124), (2014).
  • , Calcyon stimulates neuregulin 1 maturation and signaling, Molecular Psychiatry, 10.1038/mp.2014.131, 20, 10, (1251-1260), (2014).
  • , Involvement of Protein Kinase D1 in Signal Transduction from the Protein Kinase C Pathway to the Tyrosine Kinase Pathway in Response to Gonadotropin-releasing Hormone, Journal of Biological Chemistry, 10.1074/jbc.M115.681700, 290, 43, (25974-25985), (2015).
  • , Recent genetic findings in schizophrenia and their therapeutic relevance, Journal of Psychopharmacology, 10.1177/0269881114553647, 29, 2, (85-96), (2014).
  • , No Association Between NRG1 and ErbB4 Genes and Psychopathological Symptoms of Schizophrenia, NeuroMolecular Medicine, 10.1007/s12017-014-8323-9, 16, 4, (742-751), (2014).
  • , Genetics and Smoking, Current Addiction Reports, 10.1007/s40429-013-0006-3, 1, 1, (75-82), (2014).
  • , Identification of SNP barcode biomarkers for genes associated with facial emotion perception using particle swarm optimization algorithm, Annals of General Psychiatry, 10.1186/1744-859X-13-15, 13, 1, (15), (2014).
  • , Risk genes for schizophrenia: Translational opportunities for drug discovery, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2014.02.003, 143, 1, (34-50), (2014).
  • , Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases, Neuron, 10.1016/j.neuron.2014.06.007, 83, 1, (27-49), (2014).
  • , Systematic Prioritization and Integrative Analysis of Copy Number Variations in Schizophrenia Reveal Key Schizophrenia Susceptibility Genes, Schizophrenia Bulletin, 10.1093/schbul/sbu045, 40, 6, (1285-1299), (2014).
  • , Neuregulin as a Heart Failure Therapy and Mediator of Reverse Remodeling, Current Heart Failure Reports, 10.1007/s11897-013-0176-2, 11, 1, (40-49), (2013).
  • , Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample, Molecular Psychiatry, 10.1038/mp.2013.72, 19, 5, (615-624), (2013).
  • , Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia, Journal of Psychiatric Research, 10.1016/j.jpsychires.2014.02.014, 53, (125-132), (2014).
  • , Aberrant splicing in neurological diseases, Wiley Interdisciplinary Reviews: RNA, 4, 6, (631-649), (2013).
  • , Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients, Translational Psychiatry, 10.1038/tp.2013.33, 3, 5, (e264), (2013).
  • , White matter integrity as an intermediate phenotype: Exploratory genome-wide association analysis in individuals at high risk of bipolar disorder, Psychiatry Research, 10.1016/j.psychres.2012.11.002, 206, 2-3, (223-231), (2013).
  • , A “double hit” murine model for schizophrenia shows alterations in the structure and neurochemistry of the medial prefrontal cortex and the hippocampus, Neurobiology of Disease, 10.1016/j.nbd.2013.07.008, 59, (126-140), (2013).
  • , Schizophrenia Candidate Gene ERBB4: Covert Routes of Vulnerability to Psychosis Detected at the Population Level, Schizophrenia Bulletin, 10.1093/schbul/sbr169, 39, 2, (349-357), (2011).
  • , Microstructural white matter changes are correlated with the stage of psychiatric illness, Translational Psychiatry, 10.1038/tp.2013.25, 3, 4, (e248), (2013).
  • , Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology, Cellular and Molecular Life Sciences, 10.1007/s00018-013-1365-6, 70, 22, (4355-4368), (2013).
  • , Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia, Neurobiology of Disease, 10.1016/j.nbd.2012.11.013, 53, (36-48), (2013).
  • , Roles of glial cells in schizophrenia: Possible targets for therapeutic approaches, Neurobiology of Disease, 10.1016/j.nbd.2012.11.001, 53, (49-60), (2013).
  • , Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes, Neuron, 10.1016/j.neuron.2013.07.010, 79, 6, (1152-1168), (2013).
  • , Genetic association analysis of ERBB4 polymorphisms with the risk of schizophrenia and SPEM abnormality in a Korean population, Brain Research, 10.1016/j.brainres.2012.05.029, 1466, (146-151), (2012).
  • , Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity, Translational Psychiatry, 10.1038/tp.2012.25, 2, 4, (e104), (2012).
  • , Conformational Transition and Energy Landscape of ErbB4 Activated by Neuregulin1β: One Microsecond Molecular Dynamics Simulations, Journal of the American Chemical Society, 10.1021/ja211941d, 134, 15, (6720-6731), (2012).
  • , Finding a druggable target for schizophrenia: Fig. 1., Proceedings of the National Academy of Sciences, 10.1073/pnas.1209389109, 109, 30, (11902-11903), (2012).
  • , Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2011.09.011, 36, 1, (17-21), (2012).
  • , The Genetics of Schizophrenia, Schizophrenia, (109-140), (2011).
  • , Classical Genetic Studies of Schizophrenia, Schizophrenia, (245-268), (2011).
  • , Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia, Progress in Neurobiology, 10.1016/j.pneurobio.2010.09.004, 93, 1, (13-24), (2011).
  • , Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2011.02.017, 35, 4, (896-904), (2011).
  • , Genetic variants in the ErbB4 gene are associated with white matter integrity, Psychiatry Research: Neuroimaging, 10.1016/j.pscychresns.2010.11.001, 191, 2, (133-137), (2011).
  • , Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes, Translational Psychiatry, 10.1038/tp.2011.8, 1, 5, (e8), (2011).
  • , Neuregulin signaling, cortical circuitry development and schizophrenia, Current Opinion in Genetics & Development, 10.1016/j.gde.2010.12.010, 21, 3, (262-270), (2011).
  • , Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptors, Nature Medicine, 10.1038/nm.2315, 17, 4, (470-478), (2011).
  • , Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B, 1, (103-113), (2009).
  • , Aumento de los valores de las proteínas neurregulina 1 y ErbB4 en la corteza prefrontal de pacientes esquizofrénicos, Psiquiatría Biológica, 10.1016/j.psiq.2010.04.002, 17, 2, (54-62), (2010).
  • , Genetic findings in schizophrenia patients related to alterations in the intracellular Ca-homeostasis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2010.06.018, 34, 8, (1375-1380), (2010).
  • , Expressions of Neuregulin 1 and ErbB4 in Prefrontal Cortex and Hippocampus of a Rat Schizophrenia Model Induced by Chronic MK-801 Administration , Journal of Biomedicine and Biotechnology, 10.1155/2010/859516, 2010, (1-7), (2010).
  • , Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice, Hippocampus, 20, 6, (724-744), (2009).
  • , Neuregulin 1–erbB4 pathway in schizophrenia: From genes to an interactome, Brain Research Bulletin, 10.1016/j.brainresbull.2010.04.011, 83, 3-4, (132-139), (2010).
  • , The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits, Brain Research Bulletin, 10.1016/j.brainresbull.2010.07.012, 83, 3-4, (122-131), (2010).
  • , Imaging genetics of structural brain connectivity and neural integrity markers, NeuroImage, 10.1016/j.neuroimage.2009.11.030, 53, 3, (848-856), (2010).
  • , Support for the involvement of the ERBB4 gene in schizophrenia: A genetic association analysis, Neuroscience Letters, 10.1016/j.neulet.2010.06.067, 481, 2, (120-125), (2010).
  • , Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons, Proceedings of the National Academy of Sciences, 10.1073/pnas.0910302107, 107, 3, (1211-1216), (2009).
  • , Research Review: Cholinergic mechanisms, early brain development, and risk for schizophrenia, Journal of Child Psychology and Psychiatry, 51, 5, (535-549), (2009).
  • , Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain, Human Molecular Genetics, 10.1093/hmg/ddn361, 18, 3, (391-404), (2008).
  • , Update on key previously proposed candidate genes for schizophrenia, Current Opinion in Psychiatry, 10.1097/YCO.0b013e328325a598, 22, 2, (147-153), (2009).
  • , The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders, Journal of Clinical Investigation, 10.1172/JCI37934, 119, 4, (747-754), (2009).
  • , Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia, Journal of Neurodevelopmental Disorders, 10.1007/s11689-009-9017-8, 1, 4, (302-312), (2009).
  • , Altered growth factor signaling pathways as the basis of aberrant stem cell maturation in schizophrenia, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2008.11.002, 121, 1, (115-122), (2009).
  • , Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats, Neuroscience, 10.1016/j.neuroscience.2009.06.008, 163, 1, (482-489), (2009).
  • , ErbB4 Genotype Predicts Left Frontotemporal Structural Connectivity in Human Brain, Neuropsychopharmacology, 10.1038/npp.2008.112, 34, 3, (641-650), (2008).
  • , Associative learning and the genetics of schizophrenia, Trends in Neurosciences, 10.1016/j.tins.2009.01.011, 32, 6, (359-365), (2009).
  • , Cell migration in the normal and pathological postnatal mammalian brain, Progress in Neurobiology, 10.1016/j.pneurobio.2009.02.001, 88, 1, (41-63), (2009).
  • , Neuregulin-1 Modulates Hippocampal Gamma Oscillations: Implications for Schizophrenia, Cerebral Cortex, 10.1093/cercor/bhn107, 19, 3, (612-618), (2008).
  • , No association between the protein tyrosine phosphatase, receptor‐type, Z Polypeptide 1 (PTPRZ1) gene and schizophrenia in the Japanese population, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B, 7, (1013-1018), (2008).
  • , ErbB4 is a suppressor of long-term potentiation in the adult hippocampus, NeuroReport, 10.1097/WNR.0b013e3282f3da10, 19, 2, (139-143), (2008).
  • , Specific developmental reductions in subventricular zone ErbB1 and ErbB4 mRNA in the human brain, International Journal of Developmental Neuroscience, 10.1016/j.ijdevneu.2008.06.004, 26, 7, (791-803), (2008).
  • , Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population, Journal of Human Genetics, 10.1007/s10038-008-0332-9, 53, 10, (929-935), (2008).
  • , Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene, Molecular Psychiatry, 10.1038/sj.mp.4001991, 13, 2, (162-172), (2007).
  • , Neuregulin 1 in neural development, synaptic plasticity and schizophrenia, Nature Reviews Neuroscience, 10.1038/nrn2392, 9, 6, (437-452), (2008).
  • , Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia, Science, 10.1126/science.1155174, 320, 5875, (539-543), (2008).
  • , System-wide Investigation of ErbB4 Reveals 19 Sites of Tyr Phosphorylation that Are Unusually Selective in Their Recruitment Properties, Chemistry & Biology, 10.1016/j.chembiol.2008.07.006, 15, 8, (808-817), (2008).
  • , Evidence of Missense Mutations on the Neuregulin 1 Gene Affecting Function of Prepulse Inhibition, Biological Psychiatry, 10.1016/j.biopsych.2007.05.011, 63, 1, (17-23), (2008).
  • , Developing New Drugs for Schizophrenia: From Animals to the Clinic, Animal and Translational Models for CNS Drug Discovery, 10.1016/B978-0-12-373861-5.00008-4, (199-261), (2008).
  • , Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2006.04.002, 31, 1, (60-78), (2007).
  • , Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia, Human Genetics, 10.1007/s00439-006-0257-3, 120, 6, (889-906), (2006).
  • , The role of cortical inhibition in the pathophysiology and treatment of schizophrenia, Brain Research Reviews, 10.1016/j.brainresrev.2007.09.006, 56, 2, (427-442), (2007).
  • , No association between the ERBB3 gene and schizophrenia in a Japanese population, Neuroscience Research, 10.1016/j.neures.2007.01.001, 57, 4, (574-578), (2007).
  • , Molecular Genetic Study of Schizophrenia Based on Neurodevelopmental Hypothesis, Neurogenetics of Psychiatric Disorders, 10.3109/9781420019544.005, (101-116), (2010).
  • , The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity, Neuron, 10.1016/j.neuron.2007.03.028, 54, 4, (583-597), (2007).
  • , Phenotypic characterization of spatial cognition and social behavior in mice with ‘knockout’ of the schizophrenia risk gene neuregulin 1, Neuroscience, 10.1016/j.neuroscience.2007.03.051, 147, 1, (18-27), (2007).
  • , Functional Genomics and Schizophrenia: Endophenotypes and Mutant Models, Psychiatric Clinics of North America, 10.1016/j.psc.2007.04.011, 30, 3, (365-399), (2007).
  • , The FEZ1 Gene Shows No Association to Schizophrenia in Caucasian or African American Populations, Neuropsychopharmacology, 10.1038/sj.npp.1301177, 32, 1, (190-196), (2006).
  • , Neuronal migration in the adult brain: are we there yet?, Nature Reviews Neuroscience, 10.1038/nrn2074, 8, 2, (141-151), (2007).
  • , Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia, Human Molecular Genetics, 10.1093/hmg/ddl449, 16, 2, (129-141), (2006).
  • , Involvement of Neuropeptide Systems in Schizophrenia: Human Studies, Integrating the Neurobiology of Schizophrenia, 10.1016/S0074-7742(06)78011-4, (327-376), (2007).
  • , Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression, Molecular Psychiatry, 10.1038/sj.mp.4001988, 12, 9, (854-869), (2007).
  • , Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories, Molecular Psychiatry, 10.1038/sj.mp.4001906, 12, 2, (195-205), (2006).
  • , Neuregulin-1 signaling in schizophrenia, Future Neurology, 10.2217/14796708.2.5.477, 2, 5, (477-480), (2007).
  • , Two isoforms of GABAA receptor β2 subunit with different electrophysiological properties: differential expression and genotypical correlations in schizophrenia, Molecular Psychiatry, 10.1038/sj.mp.4001899, 11, 12, (1092-1105), (2006).
  • , Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology, Biological Psychiatry, 10.1016/j.biopsych.2005.11.002, 60, 2, (132-140), (2006).
  • , Schizophrenia Genes - Famine to Feast, Biological Psychiatry, 10.1016/j.biopsych.2006.06.002, 60, 2, (81-83), (2006).
  • , Exonic DNA Sequencing of ERBB4 in Bipolar Disorder, PLoS ONE, 10.1371/journal.pone.0020242, 6, 5, (e20242), (2011).
  • , Discovery, Validation and Characterization of Erbb4 and Nrg1 Haplotypes Using Data from Three Genome-Wide Association Studies of Schizophrenia, PLoS ONE, 10.1371/journal.pone.0053042, 8, 1, (e53042), (2013).
  • , Molecular Mechanisms of Schizophrenia, Cellular Physiology and Biochemistry, 10.1159/000110430, 20, 6, (687-702), (2007).
  • , Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models, Frontiers in Psychiatry, 10.3389/fpsyt.2015.00013, 6, (2015).